Editorial announcement regarding title change of Chinese Journal of Cancer to Cancer Communications

Autor Xu, Rui-Hua
Vydáno v Cancer Commun (Lond) (2018)

The progress of targeted therapy in advanced gastric cancer

Autor Qiu, Miao-zhen, Xu, Rui-hua
Vydáno 2013

Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer

Autor Luo, Hui-Yan, Xu, Rui-Hua
Vydáno 2014

Chinese Journal of Cancer reviewer acknowledgement 2015

Autor Xu, Rui-Hua, Theissen, Sarah M.
Vydáno v Chin J Cancer (2016)

The emerging role of long non-coding RNAs in the drug resistance of colorectal cancer

Autor Chen, Dong-Liang, Xu, Rui-Hua
Vydáno v Int J Clin Exp Pathol (2018)

Platinum-Based Versus Non-Platinum-Based Chemotherapy as First Line Treatment of Inoperable, Advanced Gastric Adenocarcinoma: A Meta-Analysis

Autor Chen, Wei-Wei, Wang, Feng, Xu, Rui-Hua
Vydáno 2013

Defeating cancer: the 150 most important questions in cancer research and clinical oncology

Autor Qian, Chao-Nan, Zhang, Wei, Xu, Rui-Hua
Vydáno v Chin J Cancer (2016)

Role of capecitabine in treating metastatic colorectal cancer in Chinese patients

Autor Wang, Feng, Wang, Feng-Hua, Bai, Long, Xu, Rui-Hua
Vydáno 2014

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Autor Feng, Rui-Mei, Zong, Yi-Nan, Cao, Su-Mei, Xu, Rui-Hua
Vydáno v Cancer Commun (Lond) (2019)

The Chinese Journal of Cancer is indexed in Science Citation Index (SCI) Expanded

Autor Zeng, Yi-Xin, Zhang, Wei, Qian, Chao-Nan, Xu, Rui-Hua, Ruan, Ji
Vydáno 2014

Designing gene panels for tumor mutational burden estimation: the need to shift from ‘correlation’ to ‘accuracy’

Autor Wu, Hao-Xiang, Wang, Zi-Xian, Zhao, Qi, Wang, Feng, Xu, Rui-Hua
Vydáno v J Immunother Cancer (2019)

NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications

Autor Ju, Huai-Qiang, Lin, Jin-Fei, Tian, Tian, Xie, Dan, Xu, Rui-Hua
Vydáno v Signal Transduct Target Ther (2020)

Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential

Autor Pelicano, Hélène, Zhang, Wan, Liu, Jinyun, Hammoudi, Naima, Dai, Jiale, Xu, Rui-Hua, Pusztai, Lajos, Huang, Peng
Vydáno v Breast Cancer Res (2014)

Circular RNA: metabolism, functions and interactions with proteins

Autor Zhou, Wei-Yi, Cai, Ze-Rong, Liu, Jia, Wang, De-Shen, Ju, Huai-Qiang, Xu, Rui-Hua
Vydáno v Mol Cancer (2020)

LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer

Autor Tan, Yue‐Tao, Lin, Jin‐Fei, Li, Ting, Li, Jia‐Jun, Xu, Rui‐Hua, Ju, Huai‐Qiang
Vydáno v Cancer Commun (Lond) (2020)

Comparison of prognostic nomograms based on different nodal staging systems in patients with resected gastric cancer

Autor Wang, Zi-Xian, Qiu, Miao-Zhen, Jiang, Yu-Ming, Zhou, Zhi-Wei, Li, Guo-Xin, Xu, Rui-Hua
Vydáno v J Cancer (2017)

Proposal for a New TNM Stage based on the 7(th) and 8(th) American Joint Committee on Cancer pTNM Staging Classification for Gastric Cancer

Autor Qiu, Miao-Zhen, Wang, Zi-Xian, Zhou, Yi-Xin, Yang, Da-Jun, Wang, Feng-Hua, Xu, Rui-Hua
Vydáno v J Cancer (2018)

Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types

Autor Wang, Feng, Zhao, Qi, Wang, Ying-Nan, Jin, Ying, He, Ming-Ming, Liu, Ze-Xian, Xu, Rui-Hua
Vydáno v JAMA Oncol (2019)

L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer

Autor Chen, Dong-liang, Zeng, Zhao-lei, Yang, Jing, Ren, Chao, Wang, De-shen, Wu, Wen-jing, Xu, Rui-hua
Vydáno 2013

Assessment of two different HER2 scoring systems and clinical relevance for colorectal cancer

Autor Liu, Furong, Ren, Chao, Jin, Ying, Xi, Shaoyan, He, Caiyun, Wang, Fang, Wang, Zixian, Xu, Rui-hua, Wang, Feng
Vydáno v Virchows Arch (2019)